Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PoB-EP: Expectation-driven and Placebo Modulation of Empathic Pain
NCT07367672Recruiting
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of oxytocin nasal spray (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Analgesia-weighted empathic pain ratings (R') at 45 minutes, Whole-brain multivariate predictive patterns at 45 minutes and 1 more. Started Dec 2025; status: recruiting.
02
Drugs
oxytocin nasal spray
Beyond the preview
Go deeper on NCT07367672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07367672.